-
Bacteria On Tumors Influences Immune Response, Survival Of Patients With Pancreatic Cancer
Aug 9, 2019, 09:05 AM by Michael CroftFull storyBio-IT World News Brief | A team led by researchers from The University of Texas MD Anderson Cancer Center reports that a key difference between the few pancreatic cancer patients who survive long-term and the many whose disease overcomes all treatments is the bacterial signatures on their tumors that either stimulate or suppress immune response.
-
Spring Bank Announces FDA Acceptance of IND Application for SB 11285, an IV-Administered STING Agonist, for the Treatment of Advanced Solid Tumors
Aug 8, 2019, 11:09 AM by Michael CroftHOPKINTON, MA, UNITED STATES - Aug 8, 2019 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, announced that its Investigational New Drug (IND) application for a Phase 1 trial of SB 11285, the companys intravenously (IV)-administered STING (STimulator of INterferon Gene) agonist development candidate, is now effective following clearance by the FDAFull story -
WCG Acquires PharmaSeek, LLC
Aug 8, 2019, 10:44 AM by Michael CroftPRINCETON, NJ - Aug 8, 2019 - The WIRB-Copernicus Group®s (WCG) Clinical Services Division announced the acquisition of PharmaSeek, LLC, including its wholly-owned subsidiaries PFS Clinical and PatientWise, leading providers of turn-key administrative, consulting, patient recruitment and training solutions for clinical research sitesFull story -
Shimmer Wins Two GHP International Life Sciences Awards for its Wearable Sensor Technology
Aug 7, 2019, 10:12 AM by Michael CroftCAMBRIDGE, MA, US - Aug 7, 2019 - Shimmer Research, a global leader in wearable technology for research applications, today announced that it has been honored with two GHP International Life Sciences Awards – Best Clinical Trials Wearable Sensor Technology Company USA, and Best Researcher Wearable Wireless Technology Provider 2019Full story -
BioIVT to Host Symposium Highlighting Industry Progress in Immuno-oncology Drug Discovery Research
Aug 7, 2019, 08:09 AM by Michael CroftWESTBURY, NY - Aug 7, 2019 - Aug. 7, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it will be hosting a research symposium entitled "Innovation in Immuno-oncology: Breaking Down the Barriers" on AugFull story -
LabTwin Partners with CA-based Biotech Shared Laboratory Community and Incubator; Bonneville Labs and Lab Launch Give Biotech Startups Access to World’s First Voice and AI-Powered Digital Lab Assistan
Aug 6, 2019, 13:55 PM by Michael CroftBERLIN, GERMANY - Jul 30, 2019 - LabTwin GmbH, the worlds first voice and AI-powered digital lab assistant, today announced partnerships with CA-based life science shared lab facilities Bonneville Labs and Lab LaunchFull story -
Certara Launches BaseCase Data Manager to Enhance Value-based Customer Presentations
Aug 6, 2019, 10:23 AM by Michael CroftPRINCETON, NJ - Aug 6, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of BaseCase Data Manager, which allows clients to build interactive, data-driven mobile tools using real-world data sources, such as healthcare claims, costs, quality, outcomes, and population dataFull story -
BioIVT Acquires Keystone Biologicals, Expands its Offering of Disease-state Biospecimens
Aug 6, 2019, 08:43 AM by Michael CroftWESTBURY, NY - Aug 6, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has acquired Keystone Biologicals, IncFull story -
Wisconsin State Laboratory Adopts Quantabio Products to Improve Newborn Screening for Spinal Muscular Atrophy and Severe Combined Immunodeficiency
Aug 5, 2019, 15:28 PM by Michael CroftBEVERLY, MA, UNITED STATES - Aug 5, 2019 - Quantabio, a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and life science research applications, today announced the Wisconsin State Laboratory of Hygiene has adopted its technology to improve newborn screening for Spinal Muscular Atrophy (SMA) and Severe Combined Immunodeficiency (SCID)Full story -
Patentable Subject Matter In Bioinformatics After USPTO’s January Guidance: Easier To Obtain, But Harder To Keep
Aug 5, 2019, 11:55 AM by Michael CroftFull storyBio-IT World Contributed Commentary | The United States Patent and Trademark Office released new guidance earlier this year that appears to have somewhat reversed the trend of increased patentable subject matter ineligibility for bioinformatics patent applications.
-
Signant Health Senior Vice President Dr. David Daniel Honored in PharmaVOICE 100
Aug 1, 2019, 09:04 AM by Michael CroftPLYMOUTH MEETING, PA - Aug 1, 2019 - Signant Health (formerly CRF Health and Bracket) today announces that its Senior Vice President, Dr. David Daniel, has been selected by PharmaVOICE as one of the top 100 most inspiring people within the life sciences sectorFull story -
CRISPR Patents, Oxford Nanopore, Komodo Dragons, And More: News From July 2019
Jul 31, 2019, 11:30 AM by Michael CroftBio-IT World | July featured exciting news, products, and partnerships from around the bio-IT community including CRISPR patents, Oxford Nanopore, the first high-resolution sequence of the Komodo dragon, and more.Full story -
BINDING SITE OFFERS ANTIGENS & ANTIBODIES WITH EMPHASIS ON HUMAN COAGULATION APPLICATIONS
Jul 31, 2019, 09:48 AM by Michael CroftSAN DIEGO, CA - Jul 31, 2019 - San Diego, CA . . . . Binding Sites IMMUNOLOGICALS GROUP is pleased announce that it has just completed a major expansion to their antibody and antigen product offerings for human Coagulation testing applicationsFull story -
BetterPT and BlueJay Mobile Health Announce Partnership to Expand Connectivity Between Patients, Physical Therapists and Healthcare Providers
Jul 30, 2019, 10:44 AM by Michael CroftNEW YORK, NY - Jul 30, 2019 - BetterPT, a healthcare technology platform company providing end-to-end digital connectivity between physical therapists (PT), patients, and physicians, and BlueJay Mobile Health, a full-service mobile technology company transforming healthcare delivery and care team coordination through AI-powered telehealth, today announced a partnership to bridge patients, PTs and healthcare providers through the full continuum of careFull story -
OHSU to Become First Health System in Oregon to Implement Kyruus ProviderMatch®
Jul 30, 2019, 10:17 AM by Michael CroftBOSTON, MA, UNITED STATES - Jul 30, 2019 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that OHSU in Portland, Oregon, a nationally distinguished research organization, will utilize the Kyruus ProviderMatch® platform to enhance patient access to providers and services across the OHSU health systemFull story -
MR Solutions receives a Third Queen’s Award for innovative PET imaging technology in pre-clinical scanners
Jul 30, 2019, 10:10 AM by Michael CroftGUILDFORD, UNITED KINGDOM - Jul 30, 2019 - MR Solutions has received the prestigious Queens Award for Enterprise in recognition of the companys innovative PET imaging technology for use in pre-clinical researchFull story -
X4 Pharmaceuticals Receives Orphan Drug Designation from European Commission for Mavorixafor for Treatment of WHIM Syndrome
Jul 30, 2019, 10:07 AM by Michael CroftCAMBRIDGE, MA, US - Jul 30, 2019 - X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced that the European Commission (EC), based on a favorable recommendation from the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products (COMP), has granted orphan drug designation (ODD) to mavorixafor (X4P-001) for the treatment of WHIM (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis) syndrome, a rare, inherited, primary immunodeficiency disease caused by genetic mutations in the CXCR4 receptor geneFull story -
Trinity Cyber Secures $23 Million in Funding, Led by Intel Capital, to Redefine Cybersecurity by Proactively Disrupting Cyber Attacks
Jul 30, 2019, 09:06 AM by Michael CroftBOWIE, MD - Jul 30, 2019 - Start-up Trinity Cyber achieved a major milestone with its closure today on $23 million in funding from top institutional investors led by Intel CapitalFull story -
Certara Introduces Version 19.6 of its D360 Scientific Informatics Platform
Jul 30, 2019, 08:15 AM by Michael CroftPRINCETON, NJ - Jul 30, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of version 19Full story -
How PetaGene 'Nailed It' With Their PetaSuite Protect
Jul 30, 2019, 07:00 AM by Michael CroftFull storyBio-IT World | With the rapid growth of genomic data and the need for access by cross-functional teams, it is vital to ensure that this sensitive data is adequately protected and monitored. PetaGene's PetaSuite Protect ensures that protection.